AUPH:NASDAQ GM Stock Quote - Aurinia Pharmaceuticals Inc ... Stock analysis for Aurinia Pharmaceuticals Inc (AUPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. AUPH - POSITIVE Phase 3 data; $167.7 Million offering at ... re: AUPH - POSITIVE Phase 3 data; $167.7 Million offering at $15/share Posted by go ta hell ole miss on 4/30/20 at 12:00 pm to bayoubengals88 quote: No I foolishly bought CIM and NRZ instead. AUPH Stock News and Price / Aurinia Pharmaceuticals Inc ... AUPH / Aurinia Pharmaceuticals Inc 6-K - Current Report of Foreign Issuer - AURINIA PHARMACEUTICALS INC. 6-K. 03-19 sec.gov - 1 - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Dated March 18, 2020 Commission File Number … $AUPH Stock Technical Analysis | Aurinia | SwingTradeBot.com
AUPH Stock Price and Chart — NASDAQ:AUPH — TradingView Hello, What is AUPH? Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. News Last week Aurinia Pharmaceuticals (NASDAQ: AUPH) announced that it completed a regulatory submission to the FDA seeking approval for its drug, voclosporin. AUPH | Aurinia Pharmaceuticals Inc. Stock Price & News - WSJ
Get Aurinia Pharmaceuticals Inc (AUPH:NASDAQ) real-time stock quotes, news and financial information from CNBC. AUPH:NASDAQ GM Stock Quote - Aurinia Pharmaceuticals Inc ... Stock analysis for Aurinia Pharmaceuticals Inc (AUPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. AUPH - POSITIVE Phase 3 data; $167.7 Million offering at ... re: AUPH - POSITIVE Phase 3 data; $167.7 Million offering at $15/share Posted by go ta hell ole miss on 4/30/20 at 12:00 pm to bayoubengals88 quote: No I foolishly bought CIM and NRZ instead. AUPH Stock News and Price / Aurinia Pharmaceuticals Inc ...
AUPH Institutional Ownership - Aurinia Pharmaceuticals Inc ... 237 rows AUPH Aurinia Pharmaceuticals Inc. Stock Quote Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Misses Revenue Estimates. Zacks. 04:02PM : Aurinia Reports First Quarter 2020 Financial Results and Recent Operational Highlights. Business Wire. May-07-20 06:05AM : Aurinia Pharmaceuticals to Release First Quarter 2020 Financial Results on May 14, 2020.
AUPH: Message Board for Aurinia Pharmaceuticals Inc ... Aurinia Pharmaceuticals Inc. Message board - Online Community of active, educated investors researching and discussing Aurinia Pharmaceuticals Inc. Stocks. Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Quote ... Jun 05, 2020 Aurinia Pharmaceuticals Inc. AUPH 15.78 0.80 (5.30%). NASDAQ Updated Jun 8, 2020 11:57 PM $AUPH You'd have to be an idiot to believe these bears. Not one gram of substance in their words. just poo emojis without backing evidence.